NOVO NORDISK CFO: AS VOLUMES OF WEGOVY, COMPETITOR ELI LILLY'S MOUNJARO CONTINUES TO EXPAND, PRICES WILL GO DOWN
Novo Nordisk Cfo: As Volumes Of Wegovy, Competitor Eli Lilly's…
![Reuters logo](/images/reuters.jpg)
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
919 DKK | -5.26% |
|
-5.86% | +31.64% |
05:11pm | European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading | MT |
01:48pm | Novo Nordisk to Update Weight Loss Drugs Labels Over EMA's Safety Recommendation | MT |
NOVO NORDISK CFO: AS VOLUMES OF WEGOVY, COMPETITOR ELI LILLY'S MOUNJARO CONTINUES TO EXPAND, PRICES WILL GO DOWN
1st Jan change | Capi. | |
---|---|---|
+31.64% | 627B | |
+57.33% | 848B | |
-0.77% | 363B | |
+15.01% | 318B | |
+12.20% | 299B | |
+15.43% | 243B | |
+16.74% | 225B | |
+15.87% | 179B | |
+3.40% | 167B | |
+2.52% | 125B |